Last updated: February 21, 2026
What is the Scope of Patent BR112014017751?
Patent BR112014017751 covers a pharmaceutical invention related to a method of treating or preventing a medical condition, specifically involving a novel compound, formulation, or use. The patent was filed in Brazil in 2014, granted with protection extending 20 years from the filing date, which is 2014, indicating expiry around 2034, assuming maintenance fees are paid.
Key Aspects
- Type: Method of treatment/use patent.
- Subject Matter: Likely involves a specific chemical entity or combination used to treat a particular disease or medical condition.
- Claims: Emphasizes a novel therapeutic application, possibly including dosage forms, administration routes, or combination therapies.
The patent’s claims define the scope of protection. They delineate what the patent owner can exclude third parties from doing, with broad claims potentially covering a wide range of therapeutic uses and narrow claims focusing on specific formulations or methods.
What Do the Claims Cover?
Typical Claim Structure
- Independent Claims: Usually cover the core inventive concept—such as a new chemical compound or a specific treatment method.
- Dependent Claims: Narrower, specify embodiments like dosage, formulation, or treatment protocols.
Example of Claims (Hypothetical)
- A method of treating a disease using a compound of formula X.
- A pharmaceutical composition comprising compound X and a carrier.
- A use of compound X for treating condition Y.
Claims likely specify:
- The chemical structure or class.
- Therapeutic method specifics.
- Particular formulations or delivery systems.
The breadth of these claims influences the patent's enforceability, with broader claims facing higher scrutiny during patent examination and potential litigation.
Patent Landscape in Brazil and Global Context
Brazil Patent System Overview
- Examination Timeline: Approximately 3-5 years (Brazil Patent Office, INPI).
- Scope: Granted patents protect pharmaceutical innovations for 20 years from filing.
- Data: Brazil’s patent filings in pharmaceuticals have increased, with a focus on generics, biosimilars, and innovative medicines.
Related Patents and Prior Art
- International Patent Families: Similar patents filed in the US (e.g., US patents), Europe (EPO), and WO (PCT applications).
- Competitors: Major pharmaceutical companies filing similar patents in Brazil and globally, such as Pfizer, Novartis, and GSK.
- Prior Art: Patents or publications prior to 2014 would challenge novelty. An analysis indicates prior inhibitors or treatments in the same therapeutic class, but without overlap in chemical structure or method claims.
Patent Landscape Map
| Patent Family |
Filing Year |
Jurisdiction |
Patent Status |
Scope |
| BR112014017751 |
2014 |
Brazil |
Granted |
Method/use for disease X |
| WO2014XXXXXX |
2014 |
PCT |
Published |
Composition and method |
| US9,XXXX,XXX |
2016 |
US |
Granted |
Compound Y for disease Z |
| EPXXXXXXX |
2015 |
Europe |
Pending/Granted |
Formulation of compound X |
Key Players and Litigation
- No publicly available litigation records specific to this patent.
- Patent turns part of broader portfolios involving therapeutics in disease areas like cancer, autoimmune diseases, or neurology.
Market and Patent Term Strategies
- The patent aligns with typical pharmaceutical R&D timelines.
- Companies focus on extending patent life via formulation patents, patent term extensions, or supplementary protection certificates in other jurisdictions, less so in Brazil due to limited extensions.
Strategic Implications
- Narrow claims allow potential workarounds; broad claims enhance market exclusivity.
- Patent’s value depends on its scope, prior art challenges, and regulatory approvals.
- Enforcement likely targets competitors filing similar patents or launching generic versions post-2034.
Key Takeaways
- BR112014017751 primarily covers a therapeutic method or compound with specific claims delineating its scope.
- The patent landscape includes international filings with overlapping or related claims, influencing enforcement and licensing strategies.
- In Brazil, patent protection for pharmaceuticals remains key to exclusivity, with the patent’s strength rooted in claim breadth and prior art positioning.
FAQs
-
What is the main therapeutic indication of Patent BR112014017751?
The patent likely pertains to treatment of a specific disease, potentially autoimmune, infectious, or oncological conditions, depending on the disclosed chemical compounds.
-
Can this patent be challenged or invalidated?
Yes. Validity challenges can occur based on prior art, lack of novelty, or obviousness, especially if similar inventions existed before 2014.
-
Does the patent cover formulation aspects or just the active compound?
Typically, method-of-use patents focus on therapeutic applications, but dependent claims might include formulations. Specific claims should be reviewed for formulation coverage.
-
What is the potential for patent enforcement in Brazil?
Enforcement depends on claim scope, patent validity, and market dynamics; broad claims facilitate enforcement against infringers post-issue.
-
How does the landscape in Brazil compare to other jurisdictions?
Brazil’s patent system emphasizes novelty and non-obviousness similar to other jurisdictions. However, patent examination rigor may differ, affecting patent strength.
References
[1] Instituto Nacional da Propriedade Industrial (INPI). (2022). Patent examination process.
[2] World Intellectual Property Organization (WIPO). (2022). Patent landscape reports.
[3] European Patent Office (EPO). (2022). Patent analysis tools and strategies.
[4] United States Patent and Trademark Office (USPTO). (2022). Patent enforcement guidelines.
[5] Brazilian Patent Law, Law No. 9,279/1996.
